Rheumatology Journals

Rheumatology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

A clinical trial of masitinib, a drug in development for the treatment of rheumatoid arthritis, has shown it to be well tolerated and effective. Researchers have shown that treatment with masitinib significantly reduced the severity of active arthritis.

   

Today in Popular Press...keeping you current

Pandemic toolkit offers flu with a view
EurekAlert, 12/15/09

Easily led ash-tray: Adolescent smokers prone to drug abuse
EurekAlert, 12/14/09

Pathological gambling may be successfully treated with medications for substance addiction
EurekAlert, 12/11/09